Commentary
This article is the last of a three-part series on the new Inflation Reduction Act (IRA), which takes up the proposed new health care rules in which the government lodges its inflation reduction claims. The first part of this series examined the law’s lavish spending on green initiatives. The second part assessed its dubious revenue claims.
Here, the discussion points out the harm the health care parts of the bill might cause, explaining in part why two independent analyses—one by the prestigious Penn-Wharton Model and the other by the non-partisan Congressional Budget Office (CBO)—concluded that the law would do little to reduce the rate of inflation….